Variagenics

Variagenics develops and commercializes proprietary gene variance detection technology to streamline drug development.

Variagenics develops and commercializes proprietary gene variance detection technology to streamline drug development.

Number of Funding Rounds

Total Funding Amount

1

$19M

Variagenics has raised a total of $19M in funding over 2 rounds. Their latest funding was raised on Mar 17, 2000 from a Funding Round round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 17, 2000	Funding Round	$19M	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

1

Variagenics is funded by 1 investors. Advent International are the most recent investors.

Investor Name	Lead Investor	Funding Round
Advent International	—	Funding Round